Charles Schwab’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-895,664
Closed -$118M 3624
2025
Q1
$118M Sell
895,664
-10,982
-1% -$1.45M 0.02% 574
2024
Q4
$75.7M Buy
906,646
+1,737
+0.2% +$145K 0.01% 819
2024
Q3
$66.2M Sell
904,909
-16,160
-2% -$1.18M 0.01% 913
2024
Q2
$63.1M Sell
921,069
-84,779
-8% -$5.81M 0.01% 900
2024
Q1
$69.6M Buy
1,005,848
+12,035
+1% +$833K 0.02% 803
2023
Q4
$71.2M Buy
993,813
+18,899
+2% +$1.35M 0.02% 740
2023
Q3
$50.8M Buy
974,914
+259,424
+36% +$13.5M 0.01% 869
2023
Q2
$45.3M Buy
715,490
+16,101
+2% +$1.02M 0.01% 914
2023
Q1
$37.9M Buy
699,389
+2,585
+0.4% +$140K 0.01% 1021
2022
Q4
$36.9M Buy
696,804
+16,345
+2% +$865K 0.01% 1002
2022
Q3
$31.7M Buy
680,459
+54,695
+9% +$2.54M 0.01% 1058
2022
Q2
$35.7M Buy
625,764
+18,027
+3% +$1.03M 0.01% 978
2022
Q1
$37.2M Buy
607,737
+89,260
+17% +$5.46M 0.01% 1076
2021
Q4
$27.1M Buy
518,477
+8,977
+2% +$470K 0.01% 1340
2021
Q3
$19M Buy
509,500
+18,487
+4% +$689K 0.01% 1631
2021
Q2
$20M Buy
491,013
+15,879
+3% +$648K 0.01% 1584
2021
Q1
$16.1M Buy
475,134
+17,172
+4% +$583K 0.01% 1678
2020
Q4
$14.6M Buy
457,962
+14,589
+3% +$464K 0.01% 1625
2020
Q3
$11.4M Buy
443,373
+77,997
+21% +$2M 0.01% 1603
2020
Q2
$9.38M Buy
365,376
+26,090
+8% +$670K ﹤0.01% 1691
2020
Q1
$5.22M Buy
339,286
+60,162
+22% +$925K ﹤0.01% 1809
2019
Q4
$9.58M Buy
279,124
+5,169
+2% +$177K 0.01% 1689
2019
Q3
$2.05M Buy
273,955
+2,675
+1% +$20K ﹤0.01% 2368
2019
Q2
$3.52M Buy
271,280
+3,940
+1% +$51.2K ﹤0.01% 2139
2019
Q1
$3.26M Buy
267,340
+12,289
+5% +$150K ﹤0.01% 2181
2018
Q4
$2.91M Sell
255,051
-3,244
-1% -$37K ﹤0.01% 2179
2018
Q3
$5.61M Buy
258,295
+15,118
+6% +$328K ﹤0.01% 1982
2018
Q2
$4.3M Buy
243,177
+15,379
+7% +$272K ﹤0.01% 2079
2018
Q1
$4.8M Buy
227,798
+6,357
+3% +$134K ﹤0.01% 1968
2017
Q4
$3.21M Buy
221,441
+88,258
+66% +$1.28M ﹤0.01% 2133
2017
Q3
$2.1M Sell
133,183
-1,102
-0.8% -$17.4K ﹤0.01% 2267
2017
Q2
$1.67M Sell
134,285
-3,690
-3% -$45.8K ﹤0.01% 2281
2017
Q1
$2.24M Buy
137,975
+7,335
+6% +$119K ﹤0.01% 2168
2016
Q4
$1.97M Buy
130,640
+6,709
+5% +$101K ﹤0.01% 2192
2016
Q3
$1.89M Buy
123,931
+12,984
+12% +$198K ﹤0.01% 2155
2016
Q2
$4.31M Buy
110,947
+13,782
+14% +$535K 0.01% 1663
2016
Q1
$2.7M Buy
97,165
+2,037
+2% +$56.6K ﹤0.01% 1890
2015
Q4
$5.12M Buy
95,128
+30,279
+47% +$1.63M 0.01% 1507
2015
Q3
$2.6M Sell
64,849
-8,274
-11% -$331K ﹤0.01% 1914
2015
Q2
$2.34M Buy
73,123
+8,607
+13% +$275K ﹤0.01% 1998
2015
Q1
$1.54M Buy
64,516
+3,817
+6% +$91.2K ﹤0.01% 2198
2014
Q4
$1.07M Buy
60,699
+15,768
+35% +$278K ﹤0.01% 2318
2014
Q3
$617K Buy
44,931
+1,219
+3% +$16.7K ﹤0.01% 2511
2014
Q2
$737K Buy
43,712
+24,716
+130% +$417K ﹤0.01% 2470
2014
Q1
$346K Buy
+18,996
New +$346K ﹤0.01% 2740